Friday, January 24, 2014

Biological Markers & How They Connect To Brain Tumors

By Robert Sutter


I do not think that anyone can argue against brain tumors in terms of just how complicated they are. So many different details can be uncovered and I am sure that just about all of them are going to be able to play into the nature of these growths for the sake of future remedies. As you can imagine, certain articles are going to be able to focus on them more than others. After reading up on one regarding biological markers, I feel as though I know more about the topic than ever before.

An article on Bioscience Technology went into detail about the matter. The report said that scientists at the Washington University School of Medicine in St. Louis identified a biological marker related to this type of cancer. What it may be able to do is predict the survival of those who are afflicted with these tumors. I believe that the study was worth doing, especially when considering the type of condition that has been put in place for a number of other procedures in the past.

It was later found out that those who have this marker present at higher levels are going to have more aggressive glioblastomas, the most common and aggressive growths in the brain. The article spoke about F11R, a marker that is created in the brain. Instead of being created by cancerous cells, though, it is formed by noncancerous cells, typically for the sake of protecting the healthier cells. What has been found out, though, is that it can offer support to the cancerous ones, helping them along as well.

Organizations such as Voices against Brain Cancer will be able to shed light on the situation of monocytes and their functionality in the brain. What has to be said is how they are able to adapt, being able to thrive regardless of the various biological changes that have been found in the brain. It's clear that remedies have to be found in order to keep this condition to a minimum. I believe that this is where brain tumors will be able to be brought down the most.

If there is one thing that can be said about brain tumors in general, it's that they are some of the most complex out there. Various markets can come into effect and I believe that F11R has been focused on for the right reasons. In addition, it goes to show that there is so much more information that we can uncover and go on to put to use in any kind of study imaginable. This is where, in my opinion, greater strategies are going to be able to come to the surface.




About the Author:



0 comments:

Post a Comment